We hypothesized that KCTD12 mutations might be associated with a loss of the tumor suppressor function of pfetin, leading to the acquisition of aggressive phenotypes by the tumor, similarly to the phenomenon that occurs with other tumor suppressor genes, e.g., CDH1 and TP53 [20, 21]. Here, TP53 is linked to neoplasm.